Chronic Lymphocytic Leukemia Responds to Dermal Chelation

Not Applicable

• Conditions: Chronic Lymphocytic Leukemia
• Interventions: Device: Dermal Chelation; Dietary Supplement: Nutritional Therapy

• Registration Number: NCT03495492
• Lead Sponsor: Optimum Health, Natural Healthcare Center

Brief Summary

The purpose of this clinical trial is to identify 50 participants with Chronic Lymphocytic Leukemia (CLL) and follow their total white blood cell (WBC) counts and absolute lymphocyte counts after performing dermal chelation and administering nutritional therapy

Detailed Description

The purpose of this clinical trial is to use dermal chelation and hair tissue analysis to identify 50 participants with CLL. The total wbc counts and absolute lymphocyte counts of these participants will be followed after serial dermal chelations and nutritional therapy.

Study Timeline

• Study First Submitted: 2018-02-14
• Status Verified: 2018-04
• Study First Submitted QC: 2018-04-04
• Last Update Submitted: 2018-04-04
• Study First Posted: 2018-04-12
• Last Update Posted: 2018-04-12
• Study Start: 2018-12-01
• Primary Completion: 2019-03-01
• Study Completion: 2019-03-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Clinical diagnosis of Chronic Lymphocytic Leukemia and has a toxic heavy metal load
• Toxic heavy metal load

Exclusion Criteria

• Pregnant
• Pacemaker implants
• Organ transplant recipients
• Psychotic episodes or epileptic seizures

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Participants	Nutritional Therapy	Group receiving dermal chelation and nutritional therapy
Participants	Dermal Chelation	Group receiving dermal chelation and nutritional therapy

Primary Outcome Measures

Name	Time	Method
Serial Total White Blood Cell Count	up to 12 months	Total WBC counts taken on a regular interval.